DTx Pharma Finds $100M
socalTECH
MARCH 1, 2021
San Diego-based DTx Pharma, a biotech startup which is developing RNA-based therapeutics to treat diseases, says it has raised $100M in its Series B funding round. HK), and ExSight Ventures. HK), and ExSight Ventures. As part of the funding, the company said that Matthew Hammond, Ph.D.,
Let's personalize your content